Gilead Sciences (Foster City, CA). 2024 revenue ~$28B. Antivirals: Biktarvy (HIV), Veklury (remdesivir), Sovaldi (HCV). Oncology: Kite Pharma (CAR-T, Yescarta). Nucleotide analog synthesis expertise.
12:40:41 AM · Jul 9, 2026
Sign in to reply and join the conversation.